MENU ▼
Read by QxMD icon Read
search
OPEN IN READ APP
JOURNAL ARTICLE

Erlotinib Treatment Induces Cytochrome P450 3A Activity in Non-Small Cell Lung Cancer Patients

Anna Svedberg, Svante Vikingsson, Anders Vikström, Niels Hornstra, Magnus Kentson, Eva Branden, Hirsh Koyi, Bengt Bergman, Henrik Gréen
British Journal of Clinical Pharmacology 2019 April 3
30945322

AIM: Erlotinib is a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer highly metabolized by the cytochrome P450 (CYP) 3A. Hence, the CYP3A4 activity might be a useful predictor for erlotinib pharmacokinetics in personalized medicine. The effect of erlotinib on CYP3A activity was therefore studied in non-small cell lung cancer patients.

METHODS: The study included 32 patients scheduled for erlotinib monotherapy. CYP3A activity was assessed using quinine as a probe before and during erlotinib treatment. Plasma from blood samples drawn 16 h post quinine administration were analyzed using HPLC with fluorescence detection to determine the quinine/3-OH-quinine ratio.

RESULTS: Matched samples, available from 13 patients, showed an induction of CYP3A activity (p=0.003, Wilcoxon's signed rank test) after 2 months of treatment. The quinine/3-OH-quinine ratio decreased from 20.2(± 13.4) at baseline to 11.0(± 4.34). Single-point samples, available from 19 patients, supported the decrease in ratio (p=0.007, Mann-Whitney U test). Generally, females had a higher CYP3A activity both at baseline and after two months of treatment. Statistical analysis per gender also showed significant increase in CYP3A activity (males, n=10, p=0.001, and females, n=22, p=0.001).

CONCLUSIONS: An induction of CYP3A activity was observed after two months of erlotinib treatment which was also seen when subdividing based on gender. This could be important to take into consideration for patients co-administering other CYP3A metabolizing drugs during erlotinib treatment and also makes it difficult to use baseline CYP3A activity to predict erlotinib pharmacokinetics.

Comments

You need to log in or sign up for an account to be able to comment.

No comments yet, be the first to post one!

Related Papers

Available on the App Store

Available on the Play Store
Remove bar
Read by QxMD icon Read
30945322
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"